The Autoinjectors Market Size accounted for USD 51.3 Billion in 2022 and is estimated to achieve a market size of USD 248.6 Billion by 2032 growing at a CAGR of 17.4% from 2023 to 2032.
Autoinjectors Market Highlights
- Global autoinjectors market revenue is poised to garner USD 248.6 Billion by 2032 with a CAGR of 17.4% from 2023 to 2032
- North America autoinjectors market value occupied around USD 21 billion in 2022
- Asia-Pacific autoinjectors market growth will record a CAGR of more than 18% from 2023 to 2032
- Among usage type, the disposable autoinjectors sub-segment generated over US$ 32 billion revenue in 2022
- Based on route of administration, the intramuscular sub-segment generated around 58% share in 2022
- Increasing implementation of wearable autoinjectors is a popular market trend that fuels the industry demand
Autoinjectors, also known as auto-injectors, are medical devices designed to deliver a dose of a drug through the subcutaneous or intramuscular route of administration. They were initially created to overcome hesitation associated with self-administration of needle-based drug delivery devices. These devices are easy to use and are intended for self-administration by patients or administration by untrained personnel. Moreover, the size of the injection is dependent on the drug loaded. Essentially, an autoinjector is a syringe with a pre-loaded dosage of the drug and a spring-charged needle. With the help of this device, consumers can self-administer the dosage of the drug.
Global Autoinjectors Market Dynamics
Market Drivers
- Benefits of auto-injectors in emergency medical care
- Rising incidence of diabetes and anaphylaxis
- Patients preference to choose self-administration of injections
Market Restraints
- Modes of alternative medication delivery
- High cost of auto injectors
Market Opportunities
- The requirement to limit patient visits and physical contact
- Increasing shift to therapy to home setting
Autoinjectors Market Report Coverage
| Market |
Autoinjectors Market
|
| Autoinjectors Market Size 2022 |
USD 51.3 Billion |
| Autoinjectors Market Forecast 2032 |
USD 248.6 Billion |
| Autoinjectors Market CAGR During 2023 - 2032 |
17.4% |
| Autoinjectors Market Analysis Period |
2020 - 2032 |
| Autoinjectors Market Base Year |
2022 |
| Autoinjectors Market Forecast Data |
2023 - 2032 |
| Segments Covered |
By Therapy, By Usage Type, By Route of Administration, By End-User, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
AbbVie, Inc., Amgen, Biogen Idec, Eli Lilly, Johnson & Johnson, Mylan N.V., Owen Mumford, Pfizer, Inc., Sanofi, Scandinavian Health Ltd., Teva Pharmaceutical, and Ypsomed
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Autoinjectors Market Insights
The auto-injectors market is gaining growth on account of the growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing the number of regulatory approvals, availability of generic versions of auto-injectors, favorable reimbursements and government support in developed and some developing economies, and increasing preference for self-administration due to ease of use. The increasing demand for prefilled and disposable auto-injectors due to their handiness, less probability of infection, and ease of use is further bolstering the market value. Furthermore, fundamental shifts from biologics to biosimilars, which are delivered through auto-injectors are factors anticipated to create potential opportunities over the forecast period from 2023 to 2032.
In contrast, the availability of alternative drug delivery modes, ongoing research, development, and launch of oral diabetic agents and oral insulin, and development of nasal epinephrine sprays are some of the prominent factors expected to hinder auto injectors market growth over the forecast period.
Autoinjectors Market Segmentation
The worldwide market for autoinjectors is split based on therapy, usage type, route of administration, end-user, and geography.
Autoinjectors Market, By Therapies
- Rheumatoid Arthritis
- Multiple Sclerosis
- Diabetes
- Anaphylaxis
- Other Therapies
Autoinjectors, when categorized by therapy segment, include rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. According to the autoinjectors industry analysis, the anaphylaxis therapy sub-segment dominates the market and holds the largest market share, which was nearly 37% in the past years. The prevalence of serious allergies and reactions due to various reasons such as food allergies and chronic diseases like allergic asthma has been increasing, leading to a rise in allergy-related health issues. These factors are expected to drive the auto-injectors market growth of the anaphylaxis therapy segment in the future years.
Autoinjectors Market, By Usage Types
- Disposable Autoinjectors
- Reusable Autoinjectors
Within the usage type segment, the autoinjectors are categorized into two types: disposable autoinjectors and reusable autoinjectors. The disposable autoinjectors subsegment has held the largest market share in recent years and is anticipated to continue its dominance. Reusable autoinjectors consist of two parts - prefilled and empty autoinjectors. Disposable autoinjectors are highly convenient for both patients and healthcare providers, designed for one-time use only. Additionally, disposable autoinjectors offer high safety features and help minimize needle injuries, which are key factors contributing to the growth of the auto injectors market.
Autoinjectors Market, By Route of Administrations
- Subcutaneous
- Intramuscular
The auto-injectors market, based on the route of administration, is segmented into two types: subcutaneous and intramuscular. The subcutaneous segment accounted for the largest market share in recent years. This subsegment is primarily used for various medications' delivery. Autoinjectors designed for subcutaneous administration ensure reliable absorption and help maintain therapeutic drug levels over a prolonged period, offering consistent and accurate medication delivery. These autoinjectors are specially designed for patients to effectively self-administer their medications in the comfort of their homes.
Autoinjectors Market, By End-Users
- Home Care Settings
- Hospitals & Clinics
- Ambulatory Surgical Centers
Home care settings accounted for the major revenue share in the global autoinjectors market. By end-use, the home care settings segment is experiencing increased demand in the global market. The bolstering demand for auto-injectors in home care settings especially from the developing economies is supporting the increased spending power of people on healthcare devices. The ease of use associated with the auto-injectors is ultimately increasing the demand for auto-injectors in-home care.
Autoinjectors Market, By Regions
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Autoinjectors Market Regional Analysis
North America accounted for the maximum revenue share in the autoinjectors market. In 2022, North America leads the auto-injectors market with maximum revenue share, and the region is also projected to maintain its dominance over the forecast period from 2023 to 2032. The increasing incidences of anaphylaxis, the growing prevalence of diabetes, rheumatoid arthritis, and other ailments, additionally the presence of residents with high disposable income are the factors supporting the regional market value. Moreover, the US and Canada are major contributors to the regional market value. The autoinjectors are often used in the US military to protect personnel from chemical warfare agents. Atropine and 2-PAM-Cl (pralidoxime chloride) are used for first aid against nerve agents.
Asia Pacific is anticipated to exhibit the fastest auto injectors market growth during the estimated period from 2023 to 2032. The developing economies of the Asia Pacific region are projected to support their fastest growth over the forecast period from 2023 to 2032. The increasing disposable income and number of people with the demand for therapies that use auto-injectors is further boosting the market growth. The rising prevalence of type 1 diabetes due to changing lifestyles and rapid urbanization is supporting the growth. Moreover, in China, around 50,000 children & adolescents below 20 years of age were living with type 1 diabetes in past few years and the number has increased after that.
Autoinjectors Market Players
Some of the top autoinjectors companies offered in our report includes AbbVie, Inc., Amgen, Biogen Idec, Eli Lilly, Johnson & Johnson, Mylan N.V., Owen Mumford, Pfizer, Inc., Sanofi, Scandinavian Health Ltd., Teva Pharmaceutical, Ypsomed, and others.
CHAPTER 1. Industry Overview of Autoinjectors Market
1.1. Definition and Scope
1.1.1. Definition of Autoinjectors
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Autoinjectors Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Autoinjectors Market By Therapy
1.2.3. Autoinjectors Market By Usage Type
1.2.4. Autoinjectors Market By Route of Administration
1.2.5. Autoinjectors Market By End-User
1.2.6. Autoinjectors Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Autoinjectors Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Autoinjectors Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Autoinjectors Market By Therapy
5.1. Introduction
5.2. Autoinjectors Revenue By Therapy
5.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Therapy, 2020-2032
5.2.2. Rheumatoid Arthritis
5.2.2.1. Rheumatoid Arthritis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Multiple Sclerosis
5.2.3.1. Multiple Sclerosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Diabetes
5.2.4.1. Diabetes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Anaphylaxis
5.2.5.1. Anaphylaxis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Other Therapies
5.2.6.1. Other Therapies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Autoinjectors Market By Usage Type
6.1. Introduction
6.2. Autoinjectors Revenue By Usage Type
6.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Usage Type, 2020-2032
6.2.2. Disposable Autoinjectors
6.2.2.1. Disposable Autoinjectors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Reusable Autoinjectors
6.2.3.1. Reusable Autoinjectors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Autoinjectors Market By Route of Administration
7.1. Introduction
7.2. Autoinjectors Revenue By Route of Administration
7.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Route of Administration, 2020-2032
7.2.2. Subcutaneous
7.2.2.1. Subcutaneous Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Intramuscular
7.2.3.1. Intramuscular Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Autoinjectors Market By End-User
8.1. Introduction
8.2. Autoinjectors Revenue By End-User
8.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By End-User, 2020-2032
8.2.2. Home Care Settings
8.2.2.1. Home Care Settings Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Hospitals & Clinics
8.2.3.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Ambulatory Surgical Centers
8.2.4.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Autoinjectors Market By Country
9.1. North America Autoinjectors Market Overview
9.2. U.S.
9.2.1. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
9.2.2. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
9.2.3. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.2.4. U.S. Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Canada
9.3.1. Canada Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
9.3.2. Canada Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
9.3.3. Canada Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.3.4. Canada Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Autoinjectors Market By Country
10.1. Europe Autoinjectors Market Overview
10.2. U.K.
10.2.1. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.2.2. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.2.3. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.2.4. U.K. Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Germany
10.3.1. Germany Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.3.2. Germany Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.3.3. Germany Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.3.4. Germany Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. France
10.4.1. France Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.4.2. France Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.4.3. France Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.4.4. France Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Spain
10.5.1. Spain Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.5.2. Spain Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.5.3. Spain Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.5.4. Spain Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.6.2. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.6.3. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.6.4. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Autoinjectors Market By Country
11.1. Asia Pacific Autoinjectors Market Overview
11.2. China
11.2.1. China Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.2.2. China Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.2.3. China Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.2.4. China Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. Japan
11.3.1. Japan Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.3.2. Japan Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.3.3. Japan Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.3.4. Japan Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. India
11.4.1. India Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.4.2. India Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.4.3. India Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.4.4. India Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Australia
11.5.1. Australia Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.5.2. Australia Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.5.3. Australia Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.5.4. Australia Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.6. South Korea
11.6.1. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.6.2. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.6.3. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.6.4. South Korea Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.7.2. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.7.3. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.7.4. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Autoinjectors Market By Country
12.1. Latin America Autoinjectors Market Overview
12.2. Brazil
12.2.1. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
12.2.2. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
12.2.3. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.2.4. Brazil Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.3. Mexico
12.3.1. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
12.3.2. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
12.3.3. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.3.4. Mexico Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
12.4.2. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
12.4.3. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.4.4. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Autoinjectors Market By Country
13.1. Middle East & Africa Autoinjectors Market Overview
13.2. GCC
13.2.1. GCC Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
13.2.2. GCC Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
13.2.3. GCC Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.2.4. GCC Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.3. South Africa
13.3.1. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
13.3.2. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
13.3.3. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.3.4. South Africa Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
13.4.2. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
13.4.3. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.4.4. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Autoinjectors Market
14.1. Autoinjectors Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Autoinjectors Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. AbbVie, Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. AbbVie, Inc. 2022 Autoinjectors Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Amgen
15.3. Biogen Idec
15.4. Eli Lilly
15.5. Johnson & Johnson
15.6. Mylan N.V.
15.7. Owen Mumford
15.8. Pfizer, Inc.
15.9. Sanofi
15.10. Scandinavian Health Ltd.
15.11. Teva Pharmaceutical
15.12. Ypsomed
